Aspiriant LLC’s Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index GSP Stock Holding History
Bought
Maintained
Sold
Other funds holding GSP
HW
CAM
JIC
BFG
OMC
Aspiriant LLC's GSP Position: Q1 2017 in Review
Aspiriant LLC sold out of Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index (GSP) in Q1 2017, closing a stake of 32,315 shares — an estimated $474K sold.
Aspiriant LLC first reported a position in GSP in Q2 2013 and held it in 15 quarters. The position peaked at $32.4M in Q2 2015. 20 funds tracked by Wall St. Rank hold GSP as of Q1 2017.
- Aspiriant LLC reported no remaining Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index position as of Q1 2017 after selling out during the quarter.
- Aspiriant LLC sold 32,315 Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index shares in Q1 2017, an estimated $474K.
- Aspiriant LLC first reported a position in Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index in Q2 2013 and held it in 15 quarters.
- Aspiriant LLC's Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index position peaked at $32.4M in Q2 2015.
- 20 funds tracked by Wall St. Rank held Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index as of Q1 2017.
Based on Aspiriant LLC's 13F filing for Q1 2017, filed 15 May 2017.